Effect of PEG Surface Conformation on Anticancer Activity and Blood Circulation of Nanoemulsions Loaded with Tocotrienol-Rich Fraction of Palm Oil

No abstract is available for this paper.

• Publication year

  2013

• Venue

  AAPS Journal

• Publication date

  2013-08-30

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1208/s12248-013-9525-zPMID 23990503PMCID PMC3787212
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nonlinear Absorption Kinetics of Self-Emulsifying Drug Delivery Systems (SEDDS) Containing Tocotrienols as Lipophilic Molecules: In Vivo and In Vitro Studies

  2013cited by this paper
• Incorporating the extracellular matrix : new opportunities in cancer research

  2013cited by this paper
• Concurrent delivery of tocotrienols and simvastatin by lipid nanoemulsions potentiates their antitumor activity against human mammary adenocarcenoma cells.

  2013influential reference
• “Vitamin E” fortified parenteral lipid emulsions: Plackett–Burman screening of primary process and composition parameters

  2013cited by this paper
• Nanomaterials in cancer-therapy drug delivery system.

  2013cited by this paper
• Stability and in vitro antiproliferative activity of bioactive "Vitamin E" fortified parenteral lipid emulsions.

  2013cited by this paper
• PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics.

  2012influential reference
• Routine Assessment of Cancer Cell Cytotoxicity in a Novel Three Dimensional Culture Assay Application Note 2

  2012cited by this paper
• Application of poly(ethylene glycol)–distearoylphosphatidylethanolamine (PEG-DSPE) block copolymers and their derivatives as nanomaterials in drug delivery

  2012cited by this paper
• A physical model for the size-dependent cellular uptake of nanoparticles modified with cationic surfactants

  2012influential reference
• Doxil®--the first FDA-approved nano-drug: lessons learned.

  2012cited by this paper
• Tocotrienols as possible treatments for obesity

  2012cited by this paper
• Rat Primary Hepatocytes Show Enhanced Performance and Sensitivity to Acetaminophen During Three-Dimensional Culture on a Polystyrene Scaffold Designed for Routine Use

  2011cited by this paper
• Control of the PEO chain conformation on nanoparticles by adsorption of PEO-block-poly(L-lysine) copolymers and its significance on colloidal stability and protein repellency.

  2011cited by this paper
• Alvetex®: polystyrene scaffold technology for routine three dimensional cell culture.

  2011cited by this paper
• Tocotrienols fight cancer by targeting multiple cell signaling pathways

  2011cited by this paper
• Tocotrienols and breast cancer: the evidence to date

  2011cited by this paper
• Development and validation of a reversed-phase HPLC method for the determination of γ-tocotrienol in rat and human plasma.

  2011cited by this paper
• Electrodelivery of Drugs into Cancer Cells in the Presence of Poloxamer 188

  2010cited by this paper
• A novel paclitaxel-loaded poly(epsilon-caprolactone)/Poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatment.

  2010cited by this paper
• Size-dependent endocytosis of gold nanoparticles studied by three-dimensional mapping of plasmonic scattering images

  2010cited by this paper
• Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles.

  2010cited by this paper
• The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity.

  2010cited by this paper
• Synergistic anticancer effects of combined gamma-tocotrienol and celecoxib treatment are associated with suppression in Akt and NFkappaB signaling.

  2010cited by this paper
• Enhanced antiproliferative and apoptotic response to combined treatment of γ-tocotrienol with erlotinib or gefitinib in mammary tumor cells

  2010cited by this paper
• The Value of Tocotrienols in the Prevention and Treatment of Cancer

  2010cited by this paper
• A Novel Docetaxel-Loaded Poly (ε-Caprolactone)/Pluronic F68 Nanoparticle Overcoming Multidrug Resistance for Breast Cancer Treatment

  2009cited by this paper
• [(186)Re]Liposomal doxorubicin (Doxil): in vitro stability, pharmacokinetics, imaging and biodistribution in a head and neck squamous cell carcinoma xenograft model.

  2009cited by this paper
• Nanoparticles Containing Anti-inflammatory Agents as Chemotherapy Adjuvants: Optimization and In Vitro Characterization

  2008cited by this paper
• Preparation and Characterization of a Submicron Lipid Emulsion of Docetaxel: Submicron Lipid Emulsion of Docetaxel

  2008cited by this paper
• Tocotrienols : vitamin E beyond tocopherols

  2008cited by this paper
• Synergistic Antiproliferative Effects of γ-Tocotrienol and Statin Treatment on Mammary Tumor Cells

  2007cited by this paper
• Heparanase cleavage of perlecan heparan sulfate modulates FGF10 activity during ex vivo submandibular gland branching morphogenesis

  2007cited by this paper
• Modeling tissue morphogenesis and cancer in 3D.

  2007cited by this paper
• Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding.

  2007cited by this paper
• Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential.

  2007cited by this paper
• Tocotrienols: Vitamin E beyond tocopherols.

  2006cited by this paper
• Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells.

  2006cited by this paper
• Long-circulating gadolinium-encapsulated liposomes for potential application in tumor neutron capture therapy.

  2006cited by this paper
• Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs.

  2005cited by this paper
• Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN).

  2005cited by this paper
• Design and Evaluation of an Emulsion Vehicle for Paclitaxel. I. Physicochemical Properties and Plasma Stability

  2004cited by this paper
• Interaction between erythrocytes and free phospholipids as an emulsifying agent in fat emulsions or drug carrier emulsions for intravenous injections.

  2004cited by this paper
• Distinctive alterations of invasiveness, drug resistance and cell–cell organization in 3D-cultures of MCF-7, a human breast cancer cell line, and its multidrug resistant variant

  2004cited by this paper
• Plasma protein adsorption of Tween 80- and poloxamer 188-stabilized solid lipid nanoparticles.

  2003cited by this paper
• Influence of route of administration on the absorption and disposition of alpha-, gamma- and delta-tocotrienols in rats.

  2003cited by this paper
• Therapeutic usefulness of Keishi‐bukuryo‐gan for diabetic nephropathy

  2003cited by this paper
• Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties.

  2003influential reference
• Plasma protein adsorption patterns on surfaces of Amphotericin B-containing fat emulsions.

  2003cited by this paper
• Influence of route of administration on the absorption and disposition of α,‐ γ‐ and δ‐tocotrienols in rats

  2003cited by this paper
• Physical properties and stability of two emulsion formulations of propofol.

  2001cited by this paper
• Sustained elevated plasma aprotinin concentration in mice following intraperitoneal injections of w/o emulsions incorporating aprotinin.

  2001cited by this paper
• Development of a Novel Parenteral Formulation for Tetrazepam Using a Lipid Emulsion

  2001cited by this paper
• 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption.

  2000cited by this paper
• Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption.

  2000cited by this paper
• Use of poly(ethylene glycol)-lipid conjugates to regulate the surface attributes and transfection activity of lipid-DNA particles.

  2000cited by this paper
• Poloxamers and poloxamines in nanoparticle engineering and experimental medicine.

  2000cited by this paper
• Physicochemical properties and hemolytic effect of different lipid emulsion formulations using a mixture of emulsifiers

  1999cited by this paper
• Long Circulating Liposomes: Old Drugs, New Therapeutics

  1998cited by this paper
• The non‐ionic surfactant Poloxamer 188 (RheothRx®) increases plasma and whole blood viscosity

  1998cited by this paper
• Prolonging the circulation time and modifying the body distribution of intravenously injected polystyrene nanospheres by prior intravenous administration of poloxamine-908. A 'hepatic-blockade' event or manipulation of nanosphere surface in vivo?

  1997cited by this paper
• A Novel Assay to Determine the Hemolytic Activity of Drugs Incorporated in Colloidal Carrier Systems

  1994cited by this paper
• Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol).

  1992cited by this paper
• The Mitigating Effects of Phosphatidylcholines on Bile Salt‐ and Lysophosphatidylcholine‐induced Membrane Damage

  1992cited by this paper
• Interactions of a non-ionic ABA copolymer surfactant with phospholipid monolayers: Possible relevance to emulsion stabilization

  1991cited by this paper
• Toxicity of Solubilized and Colloidal Amphotericin B Formulations to Human Erythrocytes

  1988cited by this paper
• Blood clearance and organ deposition of intravenously administered colloidal particles. The effects of particle size, nature and shape

  1982cited by this paper

• In vitro anticancer effect of epigallocatechin gallate nano-emulsion on head and neck cancers

  2025cites this paper
• Pharmacokinetics, biodistribution, and in vivo toxicity of 7-nitroindazole loaded in pegylated and non-pegylated nanoemulsions in rats.

  2024cites this paper
• Design of charge converting lipid nanoparticles via a microfluidic coating technique

  2024cites this paper
• A Concise Review on Effect of PEGylation on the Properties of Lipid-Based Nanoparticles

  2024cites this paper
• Biomacromolecule-based nanocarrier strategies to deliver plant-derived bioactive components for cancer treatment: A recent review.

  2023cites this paper
• Comparative Studies of the Uptake and Internalization Pathways of Different Lipid Nano-Systems Intended for Brain Delivery

  2023cites this paper
• Influence of the Poly(ethylene Glycol) Methyl Ether Methacrylates on the Selected Physicochemical Properties of Thermally Sensitive Polymeric Particles for Controlled Drug Delivery

  2022cites this paper
• Curcumin Loaded PEGylated Nanoemulsions Designed for Maintained Antioxidant Effects and Improved Bioavailability: A Pilot Study on Rats

  2021cites this paper
• 3D Cell Culture Systems: Tumor Application, Advantages, and Disadvantages

  2021cites this paper
• Relationship and improvement strategies between drug nanocarrier characteristics and hemocompatibility: What can we learn from the literature

  2021cites this paper
• Nanoparticulate systems and their translation potential for breast cancer therapeutics

  2021cites this paper
• Charge reversal self-emulsifying drug delivery systems: A comparative study among various phosphorylated surfactants.

  2021cites this paper
• A Nano-Emulsion Platform Functionalized with a Fully Human scFv-Fc Antibody for Atheroma Targeting: Towards a Theranostic Approach to Atherosclerosis

  2021cites this paper
• Adjuvant potency of Astragaloside VII embedded cholesterol nanoparticles for H3N2 influenza vaccine

  2020cites this paper
• Recent Development of Copolymeric Nano-Drug Delivery System for Paclitaxel.

  2020cites this paper
• Improving Glioblastoma Therapeutic Outcomes via Doxorubicin-Loaded Nanomicelles Modified with Borneol.

  2019cites this paper
• Palm Oil in Lipid-Based Formulations and Drug Delivery Systems

  2019cites this paper
• An evaluation of crude palm oil (CPO) and tocotrienol rich fraction (TRF) of palm oil as percutaneous permeation enhancers using full-thickness human skin

  2018cites this paper
• Role of Tocotrienols in Chemosensitization of Cancer

  2018cites this paper
• Design and optimization of tocotrienol rich fraction nanoemulsion system for cosmeceutical application

  2018cites this paper
• Novel sulforaphane-enabled self-microemulsifying delivery systems (SFN-SMEDDS) of taxanes: Formulation development and in vitro cytotoxicity against breast cancer cells.

  2018cites this paper
• Alvetex®, a highly porous polystyrene scaffold for routine three-dimensional cell culture

  2017cites this paper
• Enhanced Drug Delivery into Cell Cytosol via Glycoprotein H-Derived Peptide Conjugated Nanoemulsions.

  2017cites this paper
• Tumor regression and modulation of gene expression via tumor-targeted tocotrienol niosomes.

  2017cites this paper
• Extraction of Vitamin E Isomers from Palm Oil: Methodology, Characterization, and in Vitro Anti-Tumor Activity

  2017cites this paper
• Evaluation of lipid-stabilised tripropionin nanodroplets as a delivery route for combretastatin A4.

  2017cites this paper
• The Modulation of NMDA and AMPA/Kainate Receptors by Tocotrienol-Rich Fraction and Α-Tocopherol in Glutamate-Induced Injury of Primary Astrocytes

  2017cites this paper
• Developing microbubble-nanodroplet composites for enhanced hydrophobic drug delivery

  2017cites this paper
• Tocotrienol Nanoemulsion Platform of Curcumin Elicit Elevated Apoptosis and Augmentation of Anticancer Efficacy against Breast and Ovarian Carcinomas

  2016cites this paper
• Conjugation of curcumin‐loaded lipid nanoemulsions with cell‐penetrating peptides increases their cellular uptake and enhances the anti‐inflammatory effects in endothelial cells

  2016cites this paper
• Drug delivery and drug targeting with parenteral lipid nanoemulsions - A review.

  2016cites this paper
• Development and In Vitro Evaluation of Vitamin E-Enriched Nanoemulsion Vehicles Loaded with Genistein for Chemoprevention Against UVB-Induced Skin Damage.

  2015cites this paper
• Submicron Lipid Emulsions: A Versatile Platform for Drug Delivery.

  2015cites this paper
• PEGylated γ-tocotrienol isomer of vitamin E: Synthesis, characterization, in vitro cytotoxicity, and oral bioavailability.

  2015cites this paper
• SELECTED DRUG DELIVERY SYSTEMS BASED ON NANOEMULSION

  2014cites this paper
• Advances in 3D cell culture technologies enabling tissue‐like structures to be created in vitro

  2014cites this paper
• Vitamin E in Parenteral Lipid Emulsions

  2014cites this paper
• Towards designer nanoemulsions for precision delivery of therapeutics

  2014cites this paper
• Enhanced effectiveness of tocotrienol-based nano-emulsified system for topical delivery against skin carcinomas

  2014influential citation